See Public Training Course Dates and Information
DOWNLOAD CURRENT CATALOG
Request More Info
Share This Page
Subscribe to Newsletter
Improper investigation of mix-ups and errors leads to increased regulatory scrutiny and enforcement actions by the FDA. In 2010 improper failure investigations were cited in over 30% of the FDA 483 observations.
This course provides an understanding of the origin of nonconformances, including human and system errors, and a framework for the implementation of follow-up actions, including effective root cause analysis and CAPA to mitigate future problems. This program includes discussions and workshops focused on ensuring complete understanding of CAPA regulatory requirements as they relate to biopharmaceuticals. Participants will learn how to create a system for investigating and reporting deviations and other nonconformances as part of an effective quality management system. Learn more about our Pharmaceutical RA/QA practice View all Regulatory Compliance for Biopharmaceuticals courses
Learn more about our Pharmaceutical RA/QA practice View all Regulatory Compliance for Biopharmaceuticals courses
Expand All | Collapse All
This course is recommended for biopharmaceutical professionals, technicians, and general staff in quality assurance, quality control, manufacturing, metrology, or maintenance.